| Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ... The lancet 399 (10325), 629-655, 2022 | 11260 | 2022 |
| Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa NR Gandhi, A Moll, AW Sturm, R Pawinski, T Govender, U Lalloo, K Zeller, ... The Lancet 368 (9547), 1575-1580, 2006 | 2401 | 2006 |
| Comparative performance of private and public healthcare systems in low-and middle-income countries: a systematic review S Basu, J Andrews, S Kishore, R Panjabi, D Stuckler PLoS medicine 9 (6), e1001244, 2012 | 1112 | 2012 |
| Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis EW Orenstein, S Basu, NS Shah, JR Andrews, GH Friedland, AP Moll, ... The Lancet infectious diseases 9 (3), 153-161, 2009 | 782 | 2009 |
| The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017 JD Stanaway, RC Reiner, BF Blacker, EM Goldberg, IA Khalil, CE Troeger, ... The Lancet Infectious Diseases 19 (4), 369-381, 2019 | 648 | 2019 |
| Social and news media enable estimation of epidemiological patterns early in the 2010 Haitian cholera outbreak R Chunara, JR Andrews, JS Brownstein The American journal of tropical medicine and hygiene 86 (1), 39, 2012 | 576 | 2012 |
| Subcutaneous REGEN-COV antibody combination to prevent Covid-19 MP O’Brien, E Forleo-Neto, BJ Musser, F Isa, KC Chan, N Sarkar, KJ Bar, ... New England Journal of Medicine 385 (13), 1184-1195, 2021 | 505 | 2021 |
| Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosis JR Andrews, F Noubary, RP Walensky, R Cerda, E Losina, CR Horsburgh Clinical infectious diseases 54 (6), 784-791, 2012 | 457 | 2012 |
| HIV coinfection in multidrug-and extensively drug-resistant tuberculosis results in high early mortality NR Gandhi, NS Shah, JR Andrews, V Vella, AP Moll, M Scott, ... American journal of respiratory and critical care medicine 181 (1), 80-86, 2010 | 410 | 2010 |
| The global burden of tuberculosis: results from the Global Burden of Disease Study 2015 HH Kyu, ER Maddison, NJ Henry, JE Mumford, R Barber, C Shields, ... The Lancet Infectious Diseases 18 (3), 261-284, 2018 | 402 | 2018 |
| Building a tuberculosis-free world: The Lancet Commission on tuberculosis MJA Reid, N Arinaminpathy, A Bloom, BR Bloom, C Boehme, R Chaisson, ... The Lancet 393 (10178), 1331-1384, 2019 | 397 | 2019 |
| Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study OT Ranzani, MDT Hitchings, M Dorion, TL D’Agostini, RC De Paula, ... bmj 374, 2021 | 385* | 2021 |
| Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection A Natarajan, S Zlitni, EF Brooks, SE Vance, A Dahlen, H Hedlin, RM Park, ... Med 3 (6), 371-387. e9, 2022 | 349 | 2022 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 331 | 2024 |
| Proinflammatory IgG Fc structures in patients with severe COVID-19 S Chakraborty, J Gonzalez, K Edwards, V Mallajosyula, AS Buzzanco, ... Nature immunology 22 (1), 67-73, 2021 | 299 | 2021 |
| The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis L Martinez, O Cords, CR Horsburgh, JR Andrews, C Acuna-Villaorduna, ... The Lancet 395 (10228), 973-984, 2020 | 297 | 2020 |
| Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study S Basu, JR Andrews, EM Poolman, NR Gandhi, NS Shah, A Moll, ... The Lancet 370 (9597), 1500-1507, 2007 | 269 | 2007 |
| Transmission dynamics and control of cholera in Haiti: an epidemic model JR Andrews, S Basu The Lancet 377 (9773), 1248-1255, 2011 | 245 | 2011 |
| Drivers of tuberculosis transmission B Mathema, JR Andrews, T Cohen, MW Borgdorff, M Behr, JR Glynn, ... The Journal of infectious diseases 216 (suppl_6), S644-S653, 2017 | 232 | 2017 |
| Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study MDT Hitchings, OT Ranzani, MSS Torres, SB de Oliveira, M Almiron, ... The Lancet Regional Health–Americas 1, 2021 | 219* | 2021 |
Julio CrodaProfessor da Universidade Federal de Mato Grosso do Sul e Especialista da Fundação Oswaldo CruzПотвърден имейл адрес: fiocruz.br
